Innovex director awarded 5,465 common shares

Innovex International, Inc. director John Lovoi received a stock award of 5,465 shares of common stock on February 27, 2026, recorded as a grant or other acquisition at a stated price of $0.00 per share.

Rhea-AI Filing Summary

Innovex International, Inc. director John Lovoi received a stock award of 5,465 shares of common stock on February 27, 2026, recorded as a grant or other acquisition at a stated price of $0.00 per share. After this award, his directly held common stock ownership increased to 101,427 shares.

Insider Trade Summary

Grant/Award: 5,465 shares

Grant/Award 1 txn

Insider LOVOI JOHN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	5,465	$0.00	$0.00

Holdings After Transaction: Common Stock — 101,427 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Innovex International (INVX) report for John Lovoi?

Innovex International reported that director John Lovoi received a stock award of 5,465 shares of common stock. The transaction is classified as a grant or other acquisition, rather than an open-market purchase or sale, under a Form 4 insider transaction filing.

When did John Lovoi receive his Innovex International (INVX) stock award?

Director John Lovoi received his Innovex International common stock award on February 27, 2026. The Form 4 identifies this date as the official transaction date for the grant or other acquisition of 5,465 shares of the company’s common stock.

How many Innovex (INVX) shares did John Lovoi hold after this Form 4 transaction?

Following the reported grant, John Lovoi directly owned 101,427 shares of Innovex International common stock. This total reflects his holdings immediately after receiving the 5,465-share stock award disclosed in the Form 4 insider transaction report.

Was John Lovoi’s Innovex (INVX) stock award a market purchase?

No, the filing classifies the transaction as a grant, award, or other acquisition, not as a market purchase. The reported price per share is $0.00, indicating it was an awarded block of shares rather than stock bought in the open market.

What role does John Lovoi hold at Innovex International (INVX) in this Form 4?

In the Form 4, John Lovoi is identified as a director of Innovex International, Inc. The transaction therefore reflects equity compensation or a similar stock award associated with his position on the company’s board of directors.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 07:00 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LOVOI JOHN

(Last) (First) (Middle)

19120 KENSWICK DR.

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/27/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/27/2026		A		5,465	A	$0	101,427	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Matt Steinheider, Attorney-in-Fact	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.